Politicized Medicine Hindered Use of Ivermectin for COVID, according to the Journal of American Physicians and Surgeons
04 sept. 2024 11h12 HE
|
Association of American Physicians and Surgeons
The politicized response to Covid included a war on the use of ivermectin. Studies have conflicting results. The issue is at a stalemate.
Repurposed Drugs Needed for COVID-19, according to Journal of American Physicians and Surgeons
06 juin 2024 13h45 HE
|
Association of American Physicians and Surgeons
A heavily politicized process suppressed the use of safe, affordable, repurposed drugs such as hydroxychoroquine for early treatment of COVID.
Infectious Disease Specialist Calls Campaign against Repurposed Drugs in COVID-19 a ‘Great Hypocrisy’
21 mars 2024 11h01 HE
|
Association of American Physicians and Surgeons
Evidence for benefit of hydroxychloroquine and other "off-label" drugs for COVID is hidden in plain sight, says infectious disease specialist.
US Alopecia Areata Market Forecast Shows Prominent Growth by 2032, with Emerging Treatment Landscape
24 janv. 2024 10h53 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The latest...
Accountability Needed for COVID Debacle, according to the Journal of American Physicians and Surgeons
13 déc. 2023 11h51 HE
|
Association of American Physicians and Surgeons
Regulatory agencies and individuals, that have pervasive conflicts of interest, need to be held accountable for the disastrous COVID-19 response.
Global Global Antimalarial Drugs Market Research Report 2022: Increasing Prevalence of Malaria Coupled with Surge in Research for New Drugs to Propel Growth - Forecasts to 2028
17 févr. 2023 06h48 HE
|
Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By...
Global Hydroxychloroquine Market Projected to Reach Over USD 2,598.6 Million by 2028 - Vantage Market Research
16 févr. 2022 07h39 HE
|
Vantage Market Research
WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Hydroxychloroquine Market size is expected to reach over USD 2,598.6 Million by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 5.7%...
The Worldwide Rheumatoid Arthritis Drugs Industry is Expected to Reach $34.3 Billion by 2027
28 janv. 2022 05h03 HE
|
Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Drugs Market" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed analysis of rheumatoid...
Hoarding by Government Continues While Expensive New Medications for Covid Are Unavailable, States the Association of American Physicians and Surgeons (AAPS)
17 janv. 2022 13h54 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Jan. 17, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) condemns the continued hoarding by the federal government of hydroxychloroquine, which it...
Global Hydroxychloroquine Global Market Outlook 2021 to 2030: Key Players Include Bayer, Novartis, Mylan and Sanofi
30 déc. 2021 06h08 HE
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....